Evogene Ltd
EVGN1.190USD
+0.030+2.58%
Market hours （ET）Quotes delayed by 15 min
7.94MMarket Cap
LossP/E TTM
More Details of Evogene Ltd Company
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
Ticker SymbolEVGN
Company nameEvogene Ltd
IPO dateJun 11, 2007
CEODr. Arnon Heyman
Number of employees117
Security typeOrdinary Share
Fiscal year-endJun 11
Address13 Gad Feinstein Street
CityREHOVOT
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code7638517
Phone97289311900
Websitehttps://evogene.com/
Ticker SymbolEVGN
IPO dateJun 11, 2007
CEODr. Arnon Heyman
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Kenny Green
Kenny Green
Investor Relations
Investor Relations
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dan Michael Falk
Mr. Dan Michael Falk
Independent Director
Independent Director
--
--
Dr. Brian Ember
Dr. Brian Ember
Chief Executive Officer of AgPlenus Limited
Chief Executive Officer of AgPlenus Limited
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
3.63%
Recanati (Leon Yehuda)
0.96%
Jane Street Capital, L.L.C.
0.39%
UBS Financial Services, Inc.
0.22%
Morgan Stanley & Co. LLC
0.17%
Other
94.64%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
3.63%
Recanati (Leon Yehuda)
0.96%
Jane Street Capital, L.L.C.
0.39%
UBS Financial Services, Inc.
0.22%
Morgan Stanley & Co. LLC
0.17%
Other
94.64%
Shareholder Types
Shareholders
Proportion
Hedge Fund
3.78%
Individual Investor
0.96%
Research Firm
0.71%
Investment Advisor
0.34%
Venture Capital
0.12%
Investment Advisor/Hedge Fund
0.05%
Other
94.04%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
53
519.37K
5.96%
-412.34K
2025Q1
55
520.29K
6.01%
-409.22K
2024Q4
56
495.82K
9.24%
-272.31K
2024Q3
56
646.41K
12.68%
+45.84K
2024Q2
57
498.30K
80.86%
-140.56K
2024Q1
62
510.64K
10.05%
-122.17K
2023Q4
69
544.86K
11.19%
-474.65K
2023Q3
76
590.60K
14.30%
-53.35K
2023Q2
75
185.66K
4.46%
-461.57K
2023Q1
80
194.62K
4.68%
-499.69K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
316.02K
3.63%
+17.74K
+5.95%
Mar 31, 2025
Recanati (Leon Yehuda)
83.89K
0.96%
--
--
Mar 17, 2025
Jane Street Capital, L.L.C.
33.73K
0.39%
+12.39K
+58.03%
Mar 31, 2025
UBS Financial Services, Inc.
18.75K
0.22%
-3.27K
-14.84%
Mar 31, 2025
Morgan Stanley & Co. LLC
14.56K
0.17%
--
--
Mar 31, 2025
Two Sigma Investments, LP
13.56K
0.16%
+2.40K
+21.53%
Mar 31, 2025
BNP Paribas Securities Corp. North America
12.82K
0.15%
--
--
Mar 31, 2025
XTX Markets LLC
10.18K
0.12%
+10.18K
--
Mar 31, 2025
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.11%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
4.20K
0.05%
--
--
May 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Date
Type
Ratio
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
